ArticleBreast cancer research : BCR2009

Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer.

David W MilesPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.